Influence of Mast Cells on Dengue Protective Immunity and Immune Pathology

article has not abstract

Vyšlo v časopise: Influence of Mast Cells on Dengue Protective Immunity and Immune Pathology. PLoS Pathog 9(12): e32767. doi:10.1371/journal.ppat.1003783
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003783

Souhrn

article has not abstract

Zdroje

1. AbrahamSN, St. JohnAL (2010) Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10: 440–452.

2. St. JohnAL, AbrahamSN (2013) Innate immunity and its regulation by mast cells. J Immunol 190: 4458–4463.

3. PiliponskyAM, ChenCC, GrimbaldestonMA, Burns-GuydishSM, HardyJ, et al. (2010) Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 176: 926–938.

4. HalsteadSB (2007) Dengue. Lancet 370: 1644–1652.

5. ChoumetV, AttoutT, ChartierL, KhunH, SautereauJ, et al. (2012) Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and saliva-immunized mice. PLoS ONE 7: e50464. doi:10.1371/journal.pone.0050464.

6. WuSJ, Grouard-VogelG, SunW, MascolaJR, BrachtelE, et al. (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6: 816–820.

7. St. JohnAL, RathoreAP, YapH, NgML, MetcalfeDD, et al. (2011) Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A 108: 9190–9195.

8. St. JohnAL, RathoreAP, RaghavanB, NgML, AbrahamSN (2013) Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. eLife 2: e00481.

9. NilssonG, JohnellM, HammerCH, TiffanyHL, NilssonK, et al. (1996) C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157: 1693–1698.

10. DemeureCE, BrahimiK, HaciniF, MarchandF, PeronetR, et al. (2005) Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol 174: 3932–3940.

11. KunderCA, St. JohnAL, AbrahamSN (2011) Mast cell modulation of the vascular and lymphatic endothelium. Blood 118: 5383–5393.

12. ChanM, JohanssonMA (2012) The incubation periods of dengue viruses. PLoS ONE 7: e50972. doi:10.1371/journal.pone.0050972.

13. St. JohnAL, AbrahamSN, GublerDJ (2013) Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat Rev Microbiol 11: 420–426.

14. RothmanAL (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532–543.

15. ZellwegerRM, PrestwoodTR, ShrestaS (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7: 128–139.

16. HalsteadSB, O'RourkeEJ (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739–741.

17. BalsitisSJ, WilliamsKL, LachicaR, FloresD, KyleJL, et al. (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6: e1000790. doi:10.1371/journal.ppat.1000790.

18. SanchezLF, HottaH, HottaS, HommaM (1986) Degranulation and histamine release from murine mast cells sensitized with dengue virus-immune sera. Microbiol Immunol 30: 753–759.

19. KingCA, MarshallJS, AlshurafaH, AndersonR (2000) Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol 74: 7146–7150.

20. KorakaP, MurgueB, DeparisX, SetiatiTE, SuhartiC, et al. (2003) Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity. J Med Virol 70: 91–98.